Analysis of Novel Anticoagulants for Atrial Fibrillation – Pharmacokinetics and Pharmacological Considerations

Journal Title: Cardiology and Angiology: An International Journal - Year 2014, Vol 2, Issue 4

Abstract

Atrial Fibrillation (AF) is the most common arrhythmia. AF is a major risk factor for stoke. Warfarin has been available for more than 60 years and until recently it was the only oral anticoagulant used for the prevention of stroke. Despite the extensive studies and proven efficacy, its utility is limited by multiple factors. Warfarin interacts with a multitude of drugs and foods, has a delayed onset of action, has a narrow therapeutic range, requires routine lab monitoring and exhibits variable responses in patients. The novel agents dabigatran, rivaroxaban and apixaban have the potential to have some of the limitations of warfarin. This article will discuss the pharmacokinetic and pharmacological considerations and different characteristics of the novel anticoagulants when used for the prevention of AF.

Authors and Affiliations

Charlie Colquitt, Jocelyn D. Jones, Sylvia H. Jackson

Keywords

Related Articles

The Effect of Long-term Aerobic Exercises on Autonomic Imbalance in Postmenopausal Women

Objective: Study the effects of aerobic exercises on autonomic imbalance associated with menopausal women. Methods: The study included twenty postmenopausal women (age 50.7± 0.86 mean ± SEM years old). All of them under...

Cautious Use of Veno-Arterial Extracorporeal Membrane Oxygenation for MRSA Sepsis and Acute Respiratory Distress Syndrome

Extracorporeal membrane oxygenation (ECMO) for septic shock has been reported occasionally and it has been shown to have reasonable outcomes in pediatrics cases. However, the adult ECMO for septic shock is not as clearl...

Impact of Cardiovascular Exercise on Antibody Isotypes of Healthy Individuals in Eastern Nigeria

Background: Cardiovascular disease is a major public health problem & a leading cause of mortality in Nigeria, which has been largely attributed to the decline in physical exercise predisposing people to various forms of...

Clinical Significance of Creatine Kinase-MB Elevation in Patients with Chronic Kidney Disease before Initiation of Hemodialysis

Aim: To measure creatine kinase – myocardial band (CK-MB) concentration in stable patients with chronic kidney disease who had not commenced hemodialysis and determine its relationship with cardiac Troponin I and cardiov...

The Prevalence of Extra-cranial Carotid Artery Disease in Chronic Heart Failure

Background: The prevalence of carotid disease in patients with heart failure (HF) has not been described. This may be of importance for the implementation of novel interventions for heart failure that require surgery clo...

Download PDF file
  • EP ID EP344106
  • DOI 10.9734/CA/2014/11319
  • Views 96
  • Downloads 0

How To Cite

Charlie Colquitt, Jocelyn D. Jones, Sylvia H. Jackson (2014). Analysis of Novel Anticoagulants for Atrial Fibrillation – Pharmacokinetics and Pharmacological Considerations. Cardiology and Angiology: An International Journal, 2(4), 278-292. https://europub.co.uk/articles/-A-344106